A self-reporting photo-responsive nanocarrier based on RAPTA-coordinated diacetylene acts as both a delivery vehicle and a real-time monitoring agent in vitro.
Triethylamine (TEA), a well-known volatile organic amine widely used in hair-care products, medicine, textiles, fertilizers, and chemical production, is extremely harmful to human health. Therefore, there is a necessity for the development of a simple and effective system to detect TEA in a rapid and real-time manner. In this study, we have developed three different nanocomposites based on polydiacetylene (PDA)-coated metal-oxide nanoparticles (TiO2-NC, Fe2O3-NC, and SnO2-NC) that consist of N-hydroxy succinimide (NHS)-diacetylene and diacetylene co-assembly. All three nanocomposites successfully underwent topo-chemical polymerization under UV-light irradiation and subsequently exhibited a blue-to-red colour change upon exposure to TEA. The carbonyl carbon in the hydrophilic head group is more susceptible to nucleophilic attack by TEA due to NHS functionalization. Even though the reversible color transition of PDA in response to TEA was not successful, Fe2O3-NC in the aqueous phase displayed a stronger colorimetric response than the TiO2 and SnO2 nanocomposites, with a limit of detection of 86 ppb. Furthermore, the Fe2O3-NC immobilized on chitosan film facilitated naked-eye detection of TEA vapor, demonstrating its potential as a colorimetric film sensor for various real-world applications.
The clinical success of metal-based anticancer agents can be achieved by developing not only an efficient metallodrug but also a suitable drug delivery system (DDS). Although spatiotemporal delivery, enhancing the efficacy, and alleviating toxicity are achievable, modifying the mechanism of action of metallodrugs using a nano DDS remains scarce. With all this in mind, a series of cyclometalated ruthenium(II) half-sandwich complexes of the type [(η6-p-cymene)Ru(L)Cl] Ru(1)–Ru(4), where L is 2-phenylquinoline (L1), 2-(thiophen-2-yl)quinoline (L2), 4-methyl-2-phenylquinoline (L3), or 2,4-diphenylquinoline (L4), have been isolated and characterized by analytical and spectroscopic methods. Ru(1) and Ru(2) have been structurally characterized, and their coordination geometries around the ruthenium(II) are described as pseudo-octahedral geometry. Only the Ru(1) complex, which exhibited substantial cytotoxicity in non-cancerous cells and low cytotoxicity in breast cancer cells, is encapsulated into a hybrid nanosystem comprising phospholipid and polydiacetylene. The Ru(1)-entrapped nanoassembly (PDL-Ru(1)) is found to show pH-induced emission and higher release of the complex in a simulated tumor environment than in a physiological environment. Even though such a halochromic character failed to benefit cell imaging, the nanocarrier-mediated delivery has been proven to improve the cytotoxicity of Ru(1) in breast cancer cells, modulate the mode of cell death, and reduce toxicity in normal cells. Zebrafish embryo toxicity studies revealed that polydiacetylene-lipid nanoassembly could be useful for in vivo biocompatibility applications of ruthenodrug candidates.